Nanjing Medlander Medical Technology Co (SHSE:688273) Research & Development: ¥59.3 Mil (TTM As of Mar. 2026)


SHSE:688273 Nanjing Medlander Medical Technology Co Ltd SHSE:688273
82 GF Score
Price ¥38.74
GF Value ¥34.49
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Nanjing Medlander Medical Technology Co Research & Development?

Nanjing Medlander Medical Technology Co SHSE:688273 +6.40% 82 Research & Development is ¥59.3 Mil as of Mar. 2026. GuruFocus rates SHSE:688273 with a GF Score™ of 82/100 and a GF Value™ of ¥34.49 (Modestly Overvalued). The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Nanjing Medlander Medical Technology Co's Research & Development for the three months ended in Mar. 2026 was ¥12.5 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ¥59.3 Mil.

Nanjing Medlander Medical Technology Co  (SHSE:688273) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Nanjing Medlander Medical Technology Co Research & Development Related Terms

Nanjing Medlander Medical Technology Co Research & Development Historical Data

* Premium members only.

The historical data trend for Nanjing Medlander Medical Technology Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nanjing Medlander Medical Technology Co Research & Development Chart

Nanjing Medlander Medical Technology Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 37.23 41.34 58.24 57.33 61.27

Nanjing Medlander Medical Technology Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.48 13.79 14.25 18.76 12.51
SHSE:688273
82GF Score
Nanjing Medlander Medical Technology Co Ltd SHSE:688273
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nanjing Medlander Medical Technology Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥59.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ¥59.3 Mil mean?
Nanjing Medlander Medical Technology Co (SHSE:688273) has a Research & Development of ¥59.3 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Nanjing Medlander Medical Technology Co and its competitors.
Is Nanjing Medlander Medical Technology Co's Research & Development too high?
Nanjing Medlander Medical Technology Co's current Research & Development is ¥59.3 Mil. Overall, Nanjing Medlander Medical Technology Co has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nanjing Medlander Medical Technology Co's Research & Development compare to ABT and SYK?
Nanjing Medlander Medical Technology Co's Research & Development of ¥59.3 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Nanjing Medlander Medical Technology Co and its competitors. Nanjing Medlander Medical Technology Co's current Research & Development is ¥59.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nanjing Medlander Medical Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Nanjing Medlander Medical Technology Co (SHSE:688273) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥34.49, compared to a current price of ¥38.74 — trading 12.3% above its estimated fair value. The current Research & Development is ¥59.3 Mil. Nanjing Medlander Medical Technology Co's overall GF Score™ is 82/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Nanjing Medlander Medical Technology Co (SHSE:688273), the current Research & Development is ¥59.3 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nanjing Medlander Medical Technology Co (SHSE:688273) Overvalued in 2026?

Based on GuruFocus' analysis, Nanjing Medlander Medical Technology Co stock appears to be overvalued. The current stock price of ¥38.74 is trading 12.3% above its estimated GF Value™ of ¥34.49. GuruFocus considers Nanjing Medlander Medical Technology Co to be Modestly Overvalued.

Key valuation signals for SHSE:688273:

  • Research & Development: ¥59.3 Mil
  • GF Value™: ¥34.49 vs. price of ¥38.74 (12.3% above fair value)
  • GF Score™: 82/100 with 7 warning signs

No single metric tells the full story. See the SHSE:688273 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nanjing Medlander Medical Technology Co Business Description

Address Fengzhan Road, No. 32, Building A2, Yuhuatai District, Jiangsu Province, Nanjing, CHN, 210012
Nanjing Medlander Medical Technology Co Ltd is engaged in the research and development, production, sales, and service of related products in the field of pelvic floor and postpartum rehabilitation. Its products mainly include: biostimulation feedback instrument, color ultrasound diagnosis and evaluation system, magnetic stimulator, high-frequency evaluation electrocautery instrument, pelvic floor training instrument, portable postpartum recovery instrument, home pelvic floor rehabilitation therapy instrument, etc., which are widely used in obstetrics and gynecology, pelvic floor rehabilitation center, urology, anorectal department and other hospital departments.
82GF Score

Get the complete analysis for SHSE:688273

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥38.74
Price
¥34.49
GF Value